Logo image
Phase I/II randomized trial of aerobic exercise in Parkinson disease in a community setting
Journal article   Open access   Peer reviewed

Phase I/II randomized trial of aerobic exercise in Parkinson disease in a community setting

Ergun Y Uc, Kevin C Doerschug, Vincent Magnotta, Jeffrey D Dawson, Teri R Thomsen, Joel N Kline, Matthew Rizzo, Sara R Newman, Sonya Mehta, Thomas J Grabowski, …
Neurology, Vol.83(5), pp.413-425
07/29/2014
DOI: 10.1212/wnl.0000000000000644
PMCID: PMC4132568
PMID: 24991037
url
https://doi.org/10.1212/wnl.0000000000000644View
Published (Version of record) Open Access

Abstract

To (1) investigate effects of aerobic walking on motor function, cognition, and quality of life in Parkinson disease (PD), and (2) compare safety, tolerability, and fitness benefits of different forms of exercise intervention: continuous/moderate intensity vs interval/alternating between low and vigorous intensity, and individual/neighborhood vs group/facility setting. Initial design was a 6-month, 2 × 2 randomized trial of different exercise regimens in independently ambulatory patients with PD. All arms were required to exercise 3 times per week, 45 minutes per session. Randomization to group/facility setting was not feasible because of logistical factors. Over the first 2 years, we randomized 43 participants to continuous or interval training. Because preliminary analyses suggested higher musculoskeletal adverse events in the interval group and lack of difference between training methods in improving fitness, the next 17 participants were allocated only to continuous training. Eighty-one percent of 60 participants completed the study with a mean attendance of 83.3% (95% confidence interval: 77.5%-89.0%), exercising at 46.8% (44.0%-49.7%) of their heart rate reserve. There were no serious adverse events. Across all completers, we observed improvements in maximum oxygen consumption, gait speed, Unified Parkinson's Disease Rating Scale sections I and III scores (particularly axial functions and rigidity), fatigue, depression, quality of life (e.g., psychological outlook), and flanker task scores (p < 0.05 to p < 0.001). Increase in maximum oxygen consumption correlated with improvements on the flanker task and quality of life (p < 0.05). Our preliminary study suggests that aerobic walking in a community setting is safe, well tolerated, and improves aerobic fitness, motor function, fatigue, mood, executive control, and quality of life in mild to moderate PD. This study provides Class IV evidence that in patients with PD, an aerobic exercise program improves aerobic fitness, motor function, fatigue, mood, and cognition.
Parkinson Disease - therapy Residence Characteristics Humans Middle Aged Male Treatment Outcome Parkinson Disease - physiopathology Aged, 80 and over Parkinson Disease - diagnosis Quality of Life Female Aged Exercise - physiology

Details

Logo image